CORNELIS P. VAN DIJKE, M.D., Ph.D.; ROB J. HEYDENDAEL, M.D.; MARTIN J. DE KLEINE, M.D.
▸Requests for reprints should be addressed to Cornelis P. van Dijke, M.D., Ph.D.; Netherlands Centre for Monitoring of Adverse Reactions to Drugs, P.O. Box 439; 2260 AK Leidschendam, the Netherlands.
VAN DIJKE C., HEYDENDAEL R., DE KLEINE M.; Methimazole, Carbimazole, and Congenital Skin Defects. Ann Intern Med. 1987;106:60-61. doi: 10.7326/0003-4819-106-1-60
Download citation file:
Published: Ann Intern Med. 1987;106(1):60-61.
Hyperthyroidism during pregnancy generally is treated with antithyroid drugs. In their reviews of the literature, Burrow (1) and Cooper (2) have advised against the use of methimazole (thiamazole) in pregnant women with hyperthyroidism because two studies reported an association of the drug with congenital skin defects (aplasia cutis). In 1972, Milham and Elledge (3) briefly described the cases of 12 patients with congenital scalp defects and noted that in three cases, one of which included a pair of fraternal twins, the mother had taken methimazole during pregnancy. In 1975, Mujtaba and Burrow (4) reported data from their study on the
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Endocrine and Metabolism, Thyroid Disorders.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only